Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study on clinical and parasitological outcome of (a) ACT, A-L for falciparum malaria and (b) P-A for falciparum and vivax malaria in Ta-mu township, Sagaing Region

Trial Profile

Study on clinical and parasitological outcome of (a) ACT, A-L for falciparum malaria and (b) P-A for falciparum and vivax malaria in Ta-mu township, Sagaing Region

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 10 Sep 2018

At a glance

  • Drugs Artesunate/pyronaridine (Primary) ; Artemether/lumefantrine
  • Indications Falciparum malaria; Vivax malaria
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Sep 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top